In contrast, neither the IDO1 inhibitor nor the BET inhibitors greatly affected the proliferation of the cancer cells exposed to the same treatments (Fig. 5d, e), indicating that the reduction of the l-kynurenine production caused by these inhibitors is independent of their proliferative inhibition. This evidence concerns the gene IDO1 and cancer.